Rankings
▼
Calendar
SMMT (Summit Therapeutics Inc.) Stock Financials & Earnings | Market Cap Arena
SMMT
Summit Therapeutics Inc.
Mkt Cap
$12B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$1.1B
EPS (TTM)
-$1.45
Free Cash Flow (TTM)
-$324M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$537M
Q2 23
$235K
-$236K
-$16M
Q3 23
$0
-$599K
-$20M
Q4 23
$0
-$840K
-$28M
Q1 24
$0
-$27K
-$42M
Q2 24
$0
-$20K
-$60M
Q3 24
$0
-$20K
-$58M
Q4 24
$0
-$15M
-$66M
Q1 25
$0
-$25K
-$67M
Q2 25
$0
-$37K
-$568M
Q3 25
$0
-$42K
-$234M
Q4 25
$0
-$4K
$57M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
26905.5x
—
Q2 23
26905.5x
—
Q3 23
52018.3x
—
Q4 23
52174.4x
—
Q1 24
52174.4x
—
Q2 24
—
—
Q3 24
—
—
Q4 24
—
—
Q1 25
—
—
Q2 25
—
—
Q3 25
—
—
Q4 25
—
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$13M
-$13M
Q2 23
-$29M
-$29M
Q3 23
-$15M
-$15M
Q4 23
-$19M
-$19M
Q1 24
-$30M
-$30M
Q2 24
-$33M
-$33M
Q3 24
-$30M
-$30M
Q4 24
-$49M
-$49M
Q1 25
-$61M
-$62M
Q2 25
-$67M
-$67M
Q3 25
-$95M
-$95M
Q4 25
-$100M
-$100M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$53K
Q2 23
$20K
Q3 23
$53K
Q4 23
$2K
Q1 24
$4K
Q2 24
$63K
Q3 24
$58K
Q4 24
$14K
Q1 25
$422K
Q2 25
$13K
Q3 25
$71K
Q4 25
$151K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-100.0%
+2297.2%
Q2 23
+0.0%
+24.0%
Q3 23
-100.0%
+19.4%
Q4 23
-100.0%
+39.9%
Q1 24
—
-92.1%
Q2 24
-100.0%
+271.9%
Q3 24
—
+183.6%
Q4 24
—
+131.0%
Q1 25
—
+57.7%
Q2 25
—
+853.5%
Q3 25
—
+303.0%
Q4 25
—
-187.3%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
—
Q2 23
$1M
628.3%
Q3 23
$578K
—
Q4 23
$7M
—
Q1 24
$8M
—
Q2 24
$11M
—
Q3 24
$19M
—
Q4 24
$11M
—
Q1 25
$11M
—
Q2 25
$479M
—
Q3 25
$0
—
Q4 25
$243M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$10M
$7M
—
Q2 23
$9M
$6M
—
Q3 23
$15M
$5M
—
Q4 23
$19M
$12M
—
Q1 24
$31M
$12M
—
Q2 24
$31M
$14M
—
Q3 24
$38M
$20M
—
Q4 24
$51M
$14M
—
Q1 25
$51M
$16M
—
Q2 25
$208M
$360M
—
Q3 25
$131M
—
$103M
Q4 25
$147M
$78M
—
marketcaparena.com
Revenue Segments
Quarter
marketcaparena.com
Revenue by Geography
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$71M
$171M
$242M
Q2 23
$42M
$173M
$215M
Q3 23
$24M
$175M
$199M
Q4 23
$71M
$115M
$186M
Q1 24
$61M
$95M
$157M
Q2 24
$29M
$297M
$326M
Q3 24
$94M
$393M
$487M
Q4 24
$105M
$307M
$412M
Q1 25
$212M
$150M
$361M
Q2 25
$298M
$0
$298M
Q3 25
$239M
$0
$239M
Q4 25
$225M
$488M
$713M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
378M
+79.1%
Q2 23
698M
+84.5%
Q3 23
698M
+0.0%
Q4 23
702M
+0.6%
Q1 24
702M
+0.0%
Q2 24
708M
+0.9%
Q3 24
727M
+2.6%
Q4 24
738M
+1.5%
Q1 25
738M
+0.1%
Q2 25
743M
+0.6%
Q3 25
743M
+0.1%
Q4 25
748M
+0.6%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 20
$11K
79
FY 21
$17K
105
FY 22
$9K
76
FY 23
$0
105
FY 24
$0
159
FY 25
$0
200K
marketcaparena.com